Cohance Lifesciences Ltd.

NSE: COHANCE | BSE: 543064

Expensive Underperformer

Download real time

1080.50 5.30 (0.49%)

80.69% Gain from 52W Low

93,458 NSE+BSE Volume

NSE 22 May, 2025 3:31 PM (IST)

27,505.7

Market Cap

High in industry

0.5

Beta 1Year

Very Low volatility

Board Meeting

The next board meeting for Cohance Lifesciences Ltd. is on 28 May 2025 for the purpose of Audited Results See details

Cohance Lifesciences Ltd. News, Corporate filings and Earnings/Conference Calls

Keep track of all breaking news and updates on Cohance Lifesciences Ltd. from all sources in a single place.

Load latest

VOTE: Is Suven Pharmaceuticals Ltd. worth buying?

23 Votes:

Buy 65.22%

Sell 13.04%

Hold 21.74%

RESEARCH REPORTS

Buy SEE REPORTS >

Buy SEE REPORTS >